// App-Quantinova.ai

LBA11516 : Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer.

Researchers

Presenter

  • Pedram Razavi

Principal Investigators

  • Wassim Abida

  • Alex Aravanis

  • Byoungsok Jung

  • Ronglai Shen

  • Chenlu Hou

  • Ino De Bruijn

  • Sante Gnerre

  • Raymond S. Lim

  • Dalicia Reales

  • Tara Maddala

  • Michael F. Berger

  • Gregory J. Riely

  • Howard I. Scher

  • William F. Novotny

  • David B. Solit

  • Mark Lee

  • Jorge S. Reis-Filho

  • Jose Baselga

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • GRAIL, Inc., Menlo Park, CA

Locations

  • United States

Companies

  • GRAIL, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • White Blood Cell

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved